Castle Biosciences, Inc. Common Stock

$21.24
USD
Last updated on --.
24h volume528.13K
24h highest23.4200 USD
24h lowest19.6510 USD
24h Price movement+7.90%

CSTL recent prices

24 Hours
+7.90%+$1.555
30 days
-13.95%-$3.445
60 days
-9.79%-$2.305
90 days
-28.15%-$8.325

Key data

Previous close19.6900 USD
Market cap607.51M USD
Volume528.13K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.42000 USD
Net income (FY)-12.83M USD
Revenue (FY)339.92M USD
Last report dateMay 6, 2026

About Castle Biosciences, Inc. Common Stock

SERVICES-MEDICAL LABORATORIES
HeadquartersFRIENDSWOOD
Employees (FY)942.00
Revenue per employee (FY)360.85K USD
Net income per employee (FY)-13.62K USD
Listed onNasdaq
Official website

CSTL conversion tables

CSTLCSTL
USDUSD
0.5 CSTL10.62 USD
1 CSTL21.24 USD
5 CSTL106.22 USD
10 CSTL212.45 USD
USDUSD
CSTLCSTL
0.5 USD0.023535 CSTL
1 USD0.04707 CSTL
5 USD0.23535 CSTL
10 USD0.4707 CSTL

FAQ

CSTL is trading at $21.24, +7.90% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CSTL stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CSTL is currently trading at $21.24, +7.90% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CSTL price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SERVICES-MEDICAL LABORATORIES sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CSTL's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CSTL; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CSTL's historical range and other companies in the SERVICES-MEDICAL LABORATORIES sector.
Castle Biosciences, Inc. Common Stock's market cap is currently 607.51M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume528.13K
24h highest23.4200 USD
24h lowest19.6510 USD
24h Price movement+7.90%
CSTLCSTL
USDUSD
Start trade with CSTL Perpetual